155 related articles for article (PubMed ID: 36059812)
1. PRR7-AS1 Correlates with Immune Cell Infiltration and Is a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.
Lu Y; Chen S; Wang Q; Zhang J; Pei X
J Oncol; 2022; 2022():1939368. PubMed ID: 36059812
[TBL] [Abstract][Full Text] [Related]
2. INKA2-AS1 Is a Potential Promising Prognostic-Related Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
Li W; Hong G; Lai X
Mediators Inflamm; 2023; 2023():7057236. PubMed ID: 37181806
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of NPSR1-AS1 as a Novel Diagnostic and Prognostic Biomarker Involved in Immune Infiltrates in Lung Adenocarcinoma.
Zhang H; Yuan J; Xiang Y; Liu Y
J Oncol; 2022; 2022():2099327. PubMed ID: 36284635
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of
Xiao S; Huang S; Yang J
Onco Targets Ther; 2020; 13():11607-11619. PubMed ID: 33209037
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Value of Long Noncoding RNA DDX11-AS1 as a Biomarker for the Diagnosis and Prognosis of Hepatocellular Carcinoma.
Luo X; Wang Y; Zhang X; Liu W
J Oncol; 2022; 2022():5735462. PubMed ID: 36072974
[TBL] [Abstract][Full Text] [Related]
7. Correlation of Long Noncoding RNA SEMA6A-AS1 Expression with Clinical Outcome in HBV-Related Hepatocellular Carcinoma.
Yu S; Li N; Wang J; Fu Y; Huang Y; Yi P; Chen R; Tang D; Hu X; Fan X
Clin Ther; 2020 Mar; 42(3):439-447. PubMed ID: 32070484
[TBL] [Abstract][Full Text] [Related]
8. Pan-cancer analysis of super enhancer-induced PRR7-AS1 as a potential prognostic and immunological biomarker.
Wang R; Liu N; Li G; Liu J; Ma X; Liu X; Li J
Front Genet; 2023; 14():1160599. PubMed ID: 37091809
[No Abstract] [Full Text] [Related]
9. LMNTD2-AS1 regulates immune cell infiltration and promotes prostate cancer progression by targeting FUS to regulate NRF2 signal pathway.
Wu H; Liu N; He A; Li H; Liu H; Qian J; Mao W; Fu G
Am J Cancer Res; 2023; 13(8):3384-3400. PubMed ID: 37693143
[TBL] [Abstract][Full Text] [Related]
10. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
11. High Expression of Long Non-Coding RNA TMCO1-AS1 is Associated With Poor Prognosis of Hepatocellular Carcinoma.
Huang X; Zhu S; Zhang K; Tan W; Chen Y; Shang C
Front Mol Biosci; 2022; 9():814058. PubMed ID: 35141283
[No Abstract] [Full Text] [Related]
12. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
13. Construction of an Immune-Related Six-lncRNA Signature to Predict the Outcomes, Immune Cell Infiltration, and Immunotherapy Response in Patients With Hepatocellular Carcinoma.
Zhou P; Lu Y; Zhang Y; Wang L
Front Oncol; 2021; 11():661758. PubMed ID: 34277410
[TBL] [Abstract][Full Text] [Related]
14. A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis.
Wu J; Ren X; Wang N; Zhou R; Chen M; Cai Y; Lin S; Zhang H; Xie X; Dang C; Zhang S; Zhou Z
Front Genet; 2021; 12():779554. PubMed ID: 34880908
[No Abstract] [Full Text] [Related]
15. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
17. LncRNA ELF3-AS1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
Chen T; Zhu C; Wang X; Pan Y
Can J Gastroenterol Hepatol; 2021; 2021():8323487. PubMed ID: 34336727
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and Analysis of Their Functions Based on Coexpression and ceRNA Networks.
Zhao X; Bai Z; Li C; Sheng C; Li H
Biomed Res Int; 2020; 2020():8765461. PubMed ID: 32382578
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA PRR7-AS1 promotes osteosarcoma progression via binding RNF2 to transcriptionally suppress MTUS1.
Chen-Xi G; Jin-Fu X; An-Quan H; Xiao Y; Ying-Hui W; Suo-Yuan L; Cong S; Tian-Ming Z; Jun S
Front Oncol; 2023; 13():1227789. PubMed ID: 38033505
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and predictive value of the hypoxia-associated long non-coding RNA signature in hepatocellular carcinoma.
Cheng M; Zhang J; Cao PB; Zhou GQ
Yi Chuan; 2022 Feb; 44(2):153-167. PubMed ID: 35210216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]